Recombinant Human CD125/IL5RA Protein, N-His

Description of Recombinant Human CD125/IL5RA Protein, N-His

Introduction

Recombinant Human CD125/IL5RA Protein is a type of protein that is produced through genetic engineering techniques. It is also known as Interleukin-5 Receptor Alpha (IL5RA) or CD125. This protein plays a crucial role in the immune system and has been extensively studied for its structure, activity, and potential applications. In this article, we will delve deeper into the various aspects of Recombinant Human CD125/IL5RA Protein.

Structure of Recombinant Human CD125/IL5RA Protein

Recombinant Human CD125/IL5RA Protein is a glycoprotein that is composed of 428 amino acids with a molecular weight of approximately 60 kDa. It is a single-chain transmembrane protein and belongs to the type I cytokine receptor family. The extracellular domain of this protein contains a cytokine receptor homology domain, which is responsible for binding to its ligand, Interleukin-5 (IL-5). The intracellular domain of Recombinant Human CD125/IL5RA Protein has a conserved box 1 motif, which is essential for signal transduction.

Activity of Recombinant Human CD125/IL5RA Protein

Recombinant Human CD125/IL5RA Protein acts as a receptor for IL-5, a cytokine that plays a critical role in the development and function of eosinophils, a type of white blood cell. Upon binding to IL-5, Recombinant Human CD125/IL5RA Protein initiates a signaling cascade that leads to the activation of various pathways involved in cell growth, survival, and differentiation. This protein is primarily expressed on the surface of eosinophils, but it has also been found on other immune cells such as basophils and mast cells.

Applications of Recombinant Human CD125/IL5RA Protein

Recombinant Human CD125/IL5RA Protein has multiple potential applications in the field of immunology and medicine. One of the most significant applications is its role in allergic diseases, as IL-5 is known to be a key mediator in allergic inflammation. Recombinant Human CD125/IL5RA Protein has been studied as a potential therapeutic target for allergic conditions such as asthma, atopic dermatitis, and allergic rhinitis. It has also been investigated as a potential treatment for hypereosinophilic syndromes, a group of rare disorders characterized by high levels of eosinophils in the blood.

In addition to its role in allergic diseases, Recombinant Human CD125/IL5RA Protein has also been studied for its potential in cancer therapy. IL-5 has been found to play a role in the growth and survival of certain types of cancer cells, and targeting Recombinant Human CD125/IL5RA Protein has been proposed as a strategy to inhibit this effect. Furthermore, Recombinant Human CD125/IL5RA Protein has been investigated as a potential biomarker for certain types of cancer, as its expression has been found to be elevated in some cancer cells.

Recombinant Human CD125/IL5RA Protein has also been studied in the development of novel vaccines. IL-5 is known to play a role in the immune response against parasitic infections, and Recombinant Human CD125/IL5RA Protein has been used as a target for vaccine development against parasitic diseases such as schistosomiasis and leishmaniasis.

Conclusion

In summary, Recombinant Human CD125/IL5RA Protein is a crucial protein involved in the immune system and has multiple potential applications in the fields of allergy, cancer therapy, and vaccine development. Its structure and activity have been extensively studied, and ongoing research continues to uncover new insights into its role in various diseases. With its diverse range of applications, Recombinant Human CD125/IL5RA Protein holds great promise for the future of medicine.